Papers/PMID:33212907
PROFAST: A Randomized Trial Assessing the Effects of Intermittent Fasting and Lacticaseibacillus rhamnosus Probiotic among People with Prediabetes.
Nutrients2020The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
Lacticaseibacillus rhamnosus — no detected effect on serum leptin
Evidence strength: moderate.FindingNull result“Leptin levels decreased after the 3-month study period (p = 0.045), with no differences with probiotic supplementation.”
Quoted verbatim from PROFAST: A Randomized Trial Assessing the Effects of Intermittent Fasting and Lacticaseibacillus rhamnosus Probiotic among People with Prediabetes.. - Study
- RCT
- Duration
- 3 months
- Dose
- one capsule daily, 6 x 10^9 CFU, for 12 weeks
- Population
- Adults aged 18 to 65 with prediabetes and obesity, all following a 5:2 intermittent fasting regimen in both arms; 26 completers (15 probiotic, 11 placebo)
PROFAST: A Randomized Trial Assessing the Effects of Intermittent Fasting and Lacticaseibacillus rhamnosus Probiotic among People with Prediabetes.2020PMID:3321290710.3390/nu12113530Industry fundedPermalink